EUVIMEDEUVIMED entdecken
Metaanalyse

Abstract 7862: Pre-Procedural Intravenous Tirofiban and First-Pass Reperfusion in Anterior-Circulation Thrombectomy: A Meta-Analysis of Randomized Trials Stratified by Atherosclerotic Mechanism

Amiel Aragon Cortes, Yoshua Flores Bravo, Rodrigo Raul Pille Camarillo, Ricardo Alberto Orozco Santiago, José Ixta, Ana Paulina Diaz, Aldo Munoz, Nishly Alejandra De La Luz Solorzano, Yordan Jassiel Lopez Reyes, Efrain Castillo Gutierrez, Dilmareth Natera, Hugo Isaac Rubio-Lara und 2 weitere

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.7862 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Amiel Aragon Cortes und 13 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

First-pass successful reperfusion (FPSR) is a key technical determinant of recovery after endovascular thrombectomy (EVT), yet pharmacologic strategies to increase it remain undefined. Glycoprotein IIb/IIIa inhibition with tirofiban before EVT is mechanistically attractive for platelet-rich atherosclerotic occlusions, but trial results have been inconsistent, and no synthesis has isolated its effect on FPSR or tested whether benefit depends on stroke mechanism.

Methods

We performed a systematic review and meta-analysis of randomized trials comparing pre-procedural intravenous tirofiban with control in adults with acute anterior-circulation large-vessel occlusion undergoing EVT. The primary outcome was FPSR (successful reperfusion after a single device pass). Secondary outcomes were 90-day functional independence (modified Rankin Scale 0-2), symptomatic intracranial hemorrhage (sICH), and mortality. Risk ratios (RR) were pooled with random-effects models; prespecified subgroups distinguished atherosclerotic (intracranial atherosclerotic disease/large-artery atherosclerosis) from non-atherosclerotic occlusion.

Results

Two randomized trials enrolling 1,240 patients were included; first-pass reperfusion was analyzable in 1,148 (FPSR data from one trial derived from a prespecified post hoc analysis). ; Tirofiban significantly increased FPSR (RR 1.31, 95% CI 1.11-1.55; P=0.001; I 2 =0%). The effect was numerically larger in atherosclerotic (RR 1.50, 95% CI 1.17-1.91) than in non-atherosclerotic occlusion (RR 1.11, 95% CI 0.86-1.43), although the interaction was not significant (P=0.09). Tirofiban did not improve 90-day functional independence overall (RR 0.87, 95% CI 0.63-1.20); however, a significant subgroup interaction (P=0.01) revealed divergent effects—neutral in atherosclerotic occlusion (RR 1.13, 95% CI 0.86-1.48) but reduced functional independence in non-atherosclerotic occlusion (RR 0.69, 95% CI 0.52-0.91). The sICH signal was inconsistent and statistically inconclusive (RR 0.47, 95% CI 0.02-9.14; I 2 =77%); mortality did not differ (RR 1.08, 95% CI 0.83-1.40).

Conclusions

Pre-procedural tirofiban increases first-pass reperfusion during anterior-circulation thrombectomy, but this technical gain translates into functional outcomes only when the occlusion is atherosclerotic, with a signal of functional harm in non-atherosclerotic stroke. These hypothesis-generating findings argue that future phase 3 trials of adjunctive tirofiban should enrich for atherosclerotic large-vessel occlusion rather than an undifferentiated thrombectomy population.

Zitieren

APA

Cortes, A. A., Bravo, Y. F., Camarillo, R. R. P., Santiago, R. A. O., Ixta, J., Diaz, A. P., Munoz, A., Solorzano, N. A. D. L. L., Reyes, Y. J. L., Gutierrez, E. C., Natera, D., Rubio-Lara, H. I., Ramirez, A., & Mena, D. L. (2026). Abstract 7862: Pre-Procedural Intravenous Tirofiban and First-Pass Reperfusion in Anterior-Circulation Thrombectomy: A Meta-Analysis of Randomized Trials Stratified by Atherosclerotic Mechanism. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.7862

Vancouver

Cortes AA, Bravo YF, Camarillo RRP, Santiago RAO, Ixta J, Diaz AP, et al. Abstract 7862: Pre-Procedural Intravenous Tirofiban and First-Pass Reperfusion in Anterior-Circulation Thrombectomy: A Meta-Analysis of Randomized Trials Stratified by Atherosclerotic Mechanism. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.7862

BibTeX
@article{Cortes2026,
  author = {Cortes, Amiel Aragon and Bravo, Yoshua Flores and Camarillo, Rodrigo Raul Pille and Santiago, Ricardo Alberto Orozco and Ixta, José and Diaz, Ana Paulina and Munoz, Aldo and Solorzano, Nishly Alejandra De La Luz and Reyes, Yordan Jassiel Lopez and Gutierrez, Efrain Castillo and Natera, Dilmareth and Rubio-Lara, Hugo Isaac and Ramirez, Alejandro and Mena, Diego Lopez},
  title = {Abstract 7862: Pre-Procedural Intravenous Tirofiban and First-Pass Reperfusion in Anterior-Circulation Thrombectomy: A Meta-Analysis of Randomized Trials Stratified by Atherosclerotic Mechanism},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.7862}
}
Kostenlos starten →